LEVIN JEREMY M 4
4 · Ovid Therapeutics Inc. · Filed Feb 27, 2023
Insider Transaction Report
Form 4
LEVIN JEREMY M
DirectorCEO
Transactions
- Award
Stock Option (Right to Buy)
2023-02-23+600,000→ 600,000 totalExercise: $2.50Exp: 2033-02-22→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.